Gradient Investments LLC Pacira Bio Sciences, Inc. Transaction History

Gradient Investments LLC

$3.55 Billion
Q1 2024

A detailed history of Gradient Investments LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Gradient Investments LLC holds 138,427 shares of PCRX stock, worth $3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

138,427

Previous 139,949 1.09%

Holding current value

$3 Million

Previous $4.72 Million 14.34%

% of portfolio

0.11%

Previous 0.13%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$27.7 - $35.48 $42,159 - $54,000	-1,522 Reduced 1.09%	138,427 $4.04 Million
Q4 2023 Jan 18, 2024	BUY	$26.32 - $34.31 $913,909 - $1.19 Million	34,723 Added 33.0%	139,949 $4.72 Million
Q3 2023 Oct 27, 2023	BUY	$30.68 - $40.09 $101,765 - $132,978	3,317 Added 3.25%	105,226 $3.23 Million
Q2 2023 Jul 11, 2023	BUY	$36.12 - $47.5 $800,419 - $1.05 Million	22,160 Added 27.79%	101,909 $4.08 Million
Q1 2023 Apr 17, 2023	BUY	$35.53 - $43.38 $284,311 - $347,126	8,002 Added 11.15%	79,749 $3.25 Million

Q4 2022 Jan 10, 2023	BUY	$38.19 - $57.45 $570,482 - $858,188	14,938 Added 26.3%	71,747 $0
Q3 2022 Oct 14, 2022	SELL	$51.24 - $58.89 $1.7 Million - $1.95 Million	-33,153 Reduced 36.85%	56,809 $3.02 Million
Q2 2022 Jul 11, 2022	SELL	$51.49 - $81.64 $1.63 Million - $2.58 Million	-31,579 Reduced 25.98%	89,962 $5.25 Million
Q1 2022 May 26, 2022	SELL	$60.03 - $76.49 $1.12 Million - $1.43 Million	-18,632 Reduced 13.29%	121,541 $9.28 Million
Q4 2021 Jan 12, 2022	BUY	$47.97 - $62.21 $2.72 Million - $3.53 Million	56,725 Added 67.98%	140,173 $8.43 Million
Q3 2021 Oct 18, 2021	BUY	$54.64 - $61.3 $1.18 Million - $1.33 Million	21,637 Added 35.01%	83,448 $4.67 Million
Q2 2021 Jul 12, 2021	BUY	$59.18 - $69.99 $386,682 - $457,314	6,534 Added 11.82%	61,811 $3.75 Million
Q1 2021 Apr 21, 2021	BUY	$59.31 - $78.82 $3.28 Million - $4.36 Million	55,277 New	55,277 $3.87 Million
Q1 2020 Apr 07, 2020	SELL	$28.4 - $50.7 $5,793 - $10,342	-204 Closed	0 $0
Q2 2019 Jul 16, 2019	BUY	$36.57 - $47.97 $7,460 - $9,785	204 New	204 $9,000

Others Institutions Holding PCRX

# of Institutions

287

Shares Held

48.7M

Call Options Held

156K

Put Options Held

623K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $993M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Pacira Bio Sciences, Inc. Transaction History